Regulatory approval of CPX-351 for secondary AML
Charles Craddock et al.
UK NCRI AML17 trial update: everolimus addition for consolidation
Mapping the genomic landscape of Waldenström’s Macroglobulinemia
Whole genome sequencing opens door for targeted Waldenström’s therapy
Exploring treatment options against different Waldenström’s mutations